Nanotechnology: Engineering the Future of Medicine
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Nanochemistry".
Deadline for manuscript submissions: closed (1 July 2023) | Viewed by 32446
Special Issue Editors
Interests: materials science and engineering; nanotechnology; biomedicine; cancer; in vivo animal models
Interests: biopolymers; silk-based biomaterials; wound healing and regeneration; sterilization of sensitive biomedical polymers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nanotechnology has revolutionized the biomedical field. When the right tools were invented, such as scanning electron and atomic force microscopes, scientists were able to make observations at the nanoscale. With that knowledge, a new range of biomaterials emerged, such as nanoparticles and liposomes. These can be combined with drugs or diagnostic molecules to improve the ability to target specific cells or tissues and can be used as delivery systems and probes for biological diagnostics, imaging, and therapeutics. Different cells have distinctive properties, and nanotechnology can be used to recognize cells of interest, allowing associated drugs and therapeutics to reach diseased tissue, circumventing healthy cells. Nanomaterials can be functionalized with specific molecules that will bind cellular receptors for targeted delivery.
The applicability of nanotechnology in biomedicine is broad. It can be used in cancer using nanoparticles or liposomes carrying potential cancer drugs to specific cancers; in regenerative medicine using nanomaterials-assisted gene delivery to stem cells or nanostructured materials employing patients own´s cells; and in inflammatory disorders using passive targeting due to the small size and different surface properties passing through blood vessel walls into tissues.
This Special Issue aims to cover recent research on nanotechnology applied to biomedicine. Different medical applications can be endorsed, as well as diverse types of nanostructures. Types of contributions can be original research papers, short communications, and reviews.
Dr. Ana Rita Costa-Pinto
Dr. Ana Leite Oliveira
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Nanoparticles
- Nanomedicine
- Biomedicine
- Nanotechnology
- Theranostics
- Targeted delivery systems
